Related references
Note: Only part of the references are listed.Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease
Shuji Ogino et al.
MODERN PATHOLOGY (2013)
The Clinical Significance of PCDH10 Promoter Methylation in Patients with Bladder Transitional Cell Carcinoma
Ying-Li Lin et al.
UROLOGIA INTERNATIONALIS (2013)
Expression of cyclin D1a and D1b as predictive factors for treatment response in colorectal cancer
M. P. Myklebust et al.
BRITISH JOURNAL OF CANCER (2012)
Expression of oncogenic BARD1 isoforms affects colon cancer progression and correlates with clinical outcome
Y-Q Zhang et al.
BRITISH JOURNAL OF CANCER (2012)
Mutation Profiling and Microsatellite Instability in Stage II and III Colon Cancer: An Assessment of Their Prognostic and Oxaliplatin Predictive Value
Patrick G. Gavin et al.
CLINICAL CANCER RESEARCH (2012)
Epigenetic biomarkers in colorectal cancer diagnostics
James B. Rawson et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2012)
Clinical and Prognostic Significance of Protocadherin-10 (PCDH10) Promoter Methylation in Bladder Cancer
Y. L. Lin et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2012)
Relevance, Pathogenesis, and Testing Algorithm for Mismatch Repair-Defective Colorectal Carcinomas A Report of the Association for Molecular Pathology
William K. Funkhouser et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2012)
Ubiquitin C-Terminal Hydrolase L1 in Tumorigenesis
Jennifer Hurst-Kennedy et al.
BIOCHEMISTRY RESEARCH INTERNATIONAL (2012)
Thymidylate synthase expression and prognosis in colorectal cancer: a meta-analysis of colorectal cancer survival data
Yao Chen et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2012)
Neurogenesis in Colorectal Cancer Is a Marker of Aggressive Tumor Behavior and Poor Outcomes
Daniel Albo et al.
CANCER (2011)
Adjuvant Systemic Chemotherapy for Stage II and III Colon Cancer after Complete Resection: An Updated Practice Guideline
D. J. Jonker et al.
CLINICAL ONCOLOGY (2011)
Lymphovascular invasion of colorectal cancer is correlated to SPARC expression in the tumor stromal microenvironment
Tetsunori Yoshimura et al.
EPIGENETICS (2011)
Genetic and Epigenetic Traits as Biomarkers in Colorectal Cancer
Marianne Berg et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2011)
Validation Study of a Quantitative Multigene Reverse Transcriptase-Polymerase Chain Reaction Assay for Assessment of Recurrence Risk in Patients With Stage II Colon Cancer
Richard G. Gray et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Epigenetics and colorectal cancer
Victoria Valinluck Lao et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
Significance of PGP9.5 Expression in Cancer-Associated Fibroblasts for Prognosis of Colorectal Carcinoma
Yuri Akishima-Fukasawa et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2010)
Secreted protein acidic and rich in cysteine-induced cellular senescence in colorectal cancers in response to irinotecan is mediated by P53
Justin M. Chan et al.
CARCINOGENESIS (2010)
The Tumor Suppressor UCHL1 Forms a Complex with p53/MDM2/ARF to Promote p53 Signaling and Is Frequently Silenced in Nasopharyngeal Carcinoma
Lili Li et al.
CLINICAL CANCER RESEARCH (2010)
Identification of SPARC as a candidate target antigen for immunotherapy of various cancers
Mitsuhiro Inoue et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Proteomic Profiling of Proteins Associated With Lymph Node Metastasis in Colorectal Cancer
Yiming Ma et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2010)
CpG-island methylation of the ER promoter in colorectal cancer: analysis of micrometastases in lymph nodes from UICC stage I and II patients
J. Harder et al.
BRITISH JOURNAL OF CANCER (2009)
Methylation of Protocadherin 10, a Novel Tumor Suppressor, Is Associated With Poor Prognosis in Patients With Gastric Cancer
Jun Yu et al.
GASTROENTEROLOGY (2009)
CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer
Shuji Ogino et al.
GUT (2009)
High Quality Assessment of DNA Methylation in Archival Tissues from Colorectal Cancer Patients Using Quantitative High-Resolution Melting Analysis
Marija Balic et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2009)
Ubiquitin C-terminal hydrolase-L1 is a key regulator of tumor cell invasion and metastasis
H. J. Kim et al.
ONCOGENE (2009)
SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2′deoxycytidine to increase SPARC expression and improve therapy response
S. Cheetham et al.
BRITISH JOURNAL OF CANCER (2008)
The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host
Osvaldo L. Podhajcer et al.
CANCER AND METASTASIS REVIEWS (2008)
BAGE hypomethylation, a new epigenetic biomarker for colon cancer detection
Christoph Grunau et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Cadherins and cancer: how does cadherin dysfunction promote tumor progression?
A. Jeanes et al.
ONCOGENE (2008)
A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer
W. Schippinger et al.
BRITISH JOURNAL OF CANCER (2007)
Association between DNA methylation and shortened survival in patients with advanced colorectal cancer treated with 5-fluorouracil - Based chemotherapy
Lanlan Shen et al.
CLINICAL CANCER RESEARCH (2007)
Deficiency of SPARC suppresses intestinal tumorigenesis in APCMin/+ mice
Owen J. Sansom et al.
GUT (2007)
Frequent inactivation of SPARC by promoter hypermethylation in colon cancers
Eungi Yang et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer
Sergio Kaiser et al.
GENOME BIOLOGY (2007)
Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer
E. Miranda et al.
BRITISH JOURNAL OF CANCER (2006)
CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer
Daniel J. Weisenberger et al.
NATURE GENETICS (2006)
Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis
Shuji Ogino et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2006)
DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer
K Kawakami et al.
BRITISH JOURNAL OF CANCER (2006)
Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation
J Ying et al.
ONCOGENE (2006)
Genome-wide expression analysis of therapy-resistant tumors reveals SPARC as a novel target for cancer therapy
IT Tai et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Systematic review of microsatellite instability and colorectal cancer prognosis
S Popat et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
American society of clinical oncology recommendations on adjuvant chemotherapy for stage II colon cancer
AB Benson et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Gene expression profiles and molecular markers to predict recurrence of dukes' B colon cancer
YX Wang et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Kirsten ras mutations in patients with colorectal cancer:: the 'RASCAL II' study
HJN Andreyev et al.
BRITISH JOURNAL OF CANCER (2001)
Share Paper
